CARsgen Therapeutics Holdings Ltd. is a clinical-stage biopharmaceutical company, which engages in discovering, researching, and developing cell therapies. The company is headquartered in Shanghai, Shanghai and currently employs 371 full-time employees. The company went IPO on 2021-06-18. The Company’s main business is engaged in developing chimeric antigen receptor T cell (CAR T) -cell therapies to address clinical needs including but not limited to hematologic malignancies solid tumors and autoimmune diseases. The Company’s main products include zevor-cel (zevorcabtagene autoleucel), satricabtagene autoleucel and allogeneic CAR T-cell products. The firm conducts its business in the domestic and overseas markets.
02171.HK stock price ended at $14 on jeudi, after dropping 0.64%
On the latest trading day Feb 12, 2026, the stock price of 02171.HK fell by 0.64%, dropping from $14.09 to $14.00. During the session, the stock saw a volatility of 3.26%, with prices oscillating between a daily low of $13.82 and a high of $14.27. On the latest trading day, the trading volume for 02171.HK rose by 474.0K shares, despite the declining prices. This uptick in volume may signal heightened risk in the near term. In total, 964.0K shares were traded, with a market value of approximately $7.6B.
Signaux Techniques de 02171.HK
Résumé des Signaux Techniques
Acheter des signaux 0
Signaux neutres 2
Signaux de vente 5
Strong Sell
Sell
Neutral
Buy
Strong Buy
02171.HK présente actuellement 0 signaux d'achat et 5 signaux de vente. L'action est en Tendance baissière depuis 12:00 AM, avec une variation totale du prix de -0.64% pendant cette période. En général, les indicateurs techniques indiquent une tendance Strong Sell à moyen terme.
Signaux haussiers/baissiers pour 02171.HK
Nous analysons les indicateurs clés comme les moyennes mobiles, le RSI, le MACD et le volume de transactions pour générer des signaux haussiers et baissiers pour 02171.HK, vous aidant à prendre des décisions d'investissement éclairées.